Clinical Trial Update: A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Extrapancreatic Neuroendocrine Tumor [Phase 2]

View source ↗

Summary

Phase 2 trial comparing tegafur plus temozolomide with or without thalidomide in advanced extrapancreatic neuroendocrine tumor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extrapancreatic Neuroendocrine Tumor

Drugs mentioned

• Temozolomide (Temozolomide)
• Thalidomide (thalidomide)
• tegafur (tegafur)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Extrapancreatic Neuroendocrine Tumor | Phase 2 | Status: UNKNOWN